In8bio, Inc.

IN8bio’s corporate headquarters are located in NYC at the Empire State Building, 350 5th Avenue, Suite 5330, NY, NY 10118. Our research labs are in Birmingham, Alabama.

IN8bio was incorporated in the State of Delaware in 2016.

IN8bio’s shares of common stock began trading on The Nasdaq Global Market on July 30, 2021.

IN8bio’s common stock is traded on The Nasdaq Global Select Market under the symbol “INAB.”

45674E 109

IN8bio’s fiscal year end is December 31st of each year.

IN8bio’s transfer agent is Computershare Trust Company, N.A.

You can contact Computershare by calling 781-575-2000. You can email Computershare at webqueries@computershare.com.

You can use www.transfermystock.com to start the process of initiating a transfer of shares with the assistance of Computershare’s Transfer Wizard. Also, The easiest way to initiate any of these transactions would be by logging into your Investor Center account at Computershare at www.computershare.com/investor.

Shares can be purchased through any registered broker. IN8bio does not have a direct stock purchase plan.

Currently, IN8bio does not pay dividends or offer a dividend reinvestment program.

IN8bio’s independent registered public accounting firm is CohnReznick LLP.

IN8bio’s outside legal counsel is Cooley LLP.

You can find out more about IN8bio and its business on its website www.in8bio.com or contact info@in8bio.com.

Please visit the “Investor” page of our website and click on “Press Releases.”

Quarterly and annual reports, as well as other SEC filings (including proxies), can be accessed in the SEC Filings section or directly at www.sec.gov.

Information about our Management team and our Board of Directors can be found here and here.

Please contact us at ir@in8bio.com for any media inquiries.

Please visit the Investor section of our website and choose Email Alerts to be added to our distribution list.

Please visit our website for more information, or you can contact us via email at info@in8bio.com.